As of 08-2025, the promoter shareholding in Biofil Chemicals & Pharmaceuticals stands at 46.82% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Biofil Chemicals & Pharmaceuticals is 0% and 0.08% respectively.
The retail shareholding of the Biofil Chemicals & Pharmaceuticals is 53.1%.
Changes in shareholding patterns of Biofil Chemicals & Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Biofil Chemicals & Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.